Phase Therapeutics

medical devices

About

Phase Therapeutics is comprised of a team of leading experts in cryomedicine and proven commercialization partners of Lung & GI endoscopy innovations. Our mission is to improve the standards of care for lung and pancreatic cancer treatment and directly impact survival rates. We have developed the 1st and only tumor ablation platform unlocking the translumenal delivery of ultracold cryoablation. Our technology is an innovative combination of a novel mixed-phase cryogen (Pressurized sub-cooled nitrogen) compatible with Endobrochial Ultrasound (EBUS), Robotic-Assisted Bronchoscopy (RAB), and Endoscopic Ultrasound (EUS) delivery. Contact us to engage in this transformative medical device opportunity.

Technologies

Gmail Google Apps Google Cloud Hosting Varnish Mobile Friendly Wix IoT Remote

Keywords

medical equipment manufacturing immunogenic response endoscopic ultrasound frozen tumor destruction medtech outpatient cancer therapy cryobiopsy platform cryogenerator medical devices synergistic therapy endoscopic cryoablation medical equipment and supplies manufacturing mixed-phase cryogen translumenal delivery medical device collateral damage minimization minimally invasive tumor treatment real-time visualization medical technology healthcare equipment & supplies oncology single procedure cancer treatment ultracold cryoablation faster and colder cryoablation tumor ablation cryogen technology real-time ablation monitoring immunotherapy synergy b2b healthcare

Location

171 Front St, Owego, New York, United States, 13827-1520

Related Companies

Companies in the same industry